Both Th17 and ILC-3 cells produce IL-17, which inhibits tumor cell proliferation, and IL-22, which promotes tumor growth and relapse, setting up a balance between growth promotion and inhibition modulated by environmental effects [209]. The gene discussed is IL22; the disease is neoplasm.